GleamWall
中文EN

STIM Neuronetics, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1227636 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.0%
TTM net income YoY48.1%
TTM EPS YoY61.4%
Revenue 3-yr CAGR32.1%
Net income 3-yr CAGR—

Margins

Gross margin50.7%
Operating margin-9.4%
Net margin-14.4%
FCF margin-6.0%
EBITDA margin-8.0%

Returns

ROE-100.2%
ROA-16.6%
ROIC (approx.)-19.2%
Asset turnover1.15x

Leverage & solvency

Liabilities / assets83.0%
Debt / equity3.30x
Current ratio2.01x
Interest coverage-1.69x

Cash quality & payout

Operating cash flow / net income0.36x
Accruals ratio-10.7%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$41.96M$41.57M$34.45M$41.78M$37.30M$38.11M$31.98M$22.49M
Cost of revenue$20.07M$20.34M$18.30M$20.07M$20.19M$20.35M$16.24M$7.60M
Gross profit$21.89M$21.22M$16.15M$21.70M$17.11M$17.76M$15.74M$14.89M
R&D expense$1.19M$1.34M$1.36M$1.67M$1.50M$1.80M$1.62M$5.77M
SG&A expense$11.68M$11.40M$13.05M$13.34M$11.08M$12.15M$13.14M$10.78M
Operating income$541,000-$1.50M-$8.99M-$5.04M-$7.32M-$8.06M-$11.01M-$11.47M
Interest expense$2.14M$2.12M$2.27M$2.32M$2.21M$1.97M$1.92M$1.76M
Net income-$1.69M-$3.44M-$10.79M-$7.16M-$9.04M-$10.12M-$12.68M-$12.66M
EBITDA$841,000-$1.10M-$8.25M-$4.28M-$6.82M-$7.56M-$10.10M-$11.03M
EPS (basic)-0.02-0.05-0.16—-0.13-0.15-0.21—
EPS (diluted)-0.02-0.05-0.16—-0.13-0.15-0.21—
Weighted avg. shares (diluted)77.00M73.13M69.59M—67.31M66.18M61.47M—
Balance sheet
Cash & equivalents$22.11M$19.20M$13.21M$28.13M$27.97M$10.97M$20.22M$19.46M
Receivables$14.44M$15.96M$15.81M$16.47M$18.69M$26.12M$26.20M$23.36M
Inventory$4.94M$5.50M$4.71M$4.33M$4.32M$4.94M$4.07M$4.25M
Current assets$53.89M$53.23M$47.17M$61.55M$64.89M$56.14M$60.67M$58.12M
PP&E, net$3.18M$3.46M$3.87M$4.47M$4.94M$5.32M$5.85M$6.24M
Goodwill$23.62M$23.62M$23.62M$23.62M$22.66M$19.08M$18.63M$18.63M
Intangibles$17.06M$17.42M$17.79M$18.15M$18.51M$18.88M$19.24M$19.61M
Total assets$131.96M$131.53M$125.44M$141.55M$145.47M$134.65M$141.99M$140.90M
Current liabilities$26.86M$28.31M$28.29M$30.52M$28.94M$27.80M$24.84M$31.27M
Long-term debt$61.75M$61.52M$61.30M$65.81M$65.67M$55.54M$55.34M$55.15M
Total debt$61.75M$61.52M$61.30M$65.81M$65.67M$55.54M$55.34M$55.15M
Total liabilities$109.56M$109.89M$108.38M$115.31M$114.11M$103.14M$102.46M$109.10M
Shareholders' equity$18.71M$17.85M$13.27M$22.38M$27.36M$27.15M$35.45M$27.71M
Net debt$39.65M$42.32M$48.08M$37.67M$37.70M$44.57M$35.12M$35.69M
Shares outstanding77.73M76.19M69.58M68.99M68.44M66.11M65.82M55.68M
Cash flow statement
Operating cash flow$1.24M-$1.01M-$9.42M$908,000-$785,000-$3.50M-$16.99M-$8.60M
Capital expenditure$470,000$417,000$197,000$216,000$114,000$252,000$219,000$89,000
Free cash flow$768,000-$1.43M-$9.62M$692,000-$899,000-$3.76M-$17.21M-$8.69M
Investing cash flow-$470,000-$417,000-$172,000-$216,000-$114,000-$252,000-$219,000-$2.38M
Financing cash flow$2.14M$7.41M-$5.58M-$1.03M$17.90M$1,000$18.98M$9.56M
Depreciation & amortization$300,000$400,000$745,000$767,000$500,000$500,000$911,000$446,000
Stock-based compensation$178,000$688,000$1.68M$2.18M$1.41M$1.81M$1.44M$1.28M

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.